HealthEquity (HQY) Tops Q3 EPS by 1c, Boosts FY15 Guidance
HealthEquity (NASDAQ: HQY) reported Q3 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $21.9 million versus the consensus estimate of $21 million.
HealthEquity sees FY2015 EPS of $0.19-$0.21, versus the consensus of $0.18. HealthEquity sees FY2015 revenue of $85-87 million, versus the consensus of $84.62 million. Adjusted EBITDA is expected to be between $23.0 million and $25.0 million.
For earnings history and earnings-related data on HealthEquity (HQY) click here.
